Sugiura Fumiaki, Kitoh Hiroshi, Ishiguro Naoki
Department of Orthopaedic Surgery, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
Biochem Biophys Res Commun. 2004 Mar 26;316(1):233-9. doi: 10.1016/j.bbrc.2004.02.038.
Osteogenic potential of serially passaged rat bone marrow derived mesenchymal stem cells (BMCs) was evaluated for clinical feasibility. Osteogenic differentiation in vitro was evaluated by means of the concentration and mRNA expression of alkaline phosphatase and osteocalcin. For in vivo osteogenesis, BMCs in various degrees of differentiation were implanted into the athymic mice. Although elevated levels of osteogenic markers were prominent in the less passaged BMCs continuously cultured with osteogenic supplements (OS group), they decreased with passaging. Similar to the in vitro experiments, abundant bone and cartilage formations inside the membrane were observed in the P0 through P2 cells of the OS group. In the P3 cells, however, the chambers were filled with fibrous tissues showing the failure of osteogenesis. Establishment of the culture conditions that permit the rapid expansion of BMCs while retaining their potential for differentiation will be required for future clinical applications.
为评估其临床可行性,对连续传代的大鼠骨髓间充质干细胞(BMCs)的成骨潜力进行了评估。通过碱性磷酸酶和骨钙素的浓度及mRNA表达来评估体外成骨分化。对于体内成骨,将不同分化程度的BMCs植入无胸腺小鼠体内。尽管在用成骨补充剂连续培养的传代次数较少的BMCs中(OS组),成骨标志物水平升高很明显,但它们会随着传代而降低。与体外实验相似,在OS组的P0至P2细胞中,在膜内观察到大量骨和软骨形成。然而,在P3细胞中,小室充满了纤维组织,显示成骨失败。未来临床应用需要建立能够在保留BMCs分化潜能的同时允许其快速扩增的培养条件。